Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Generic carve-outs would increase costs by $US29b over next decade

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Pharmaceutical Care Management Association.New PCMA Research: State Legislative Proposals Restricting Access to Generic Medicines Would Increase Costs $29 Billion Over 10 Years. Media Release: 3 Oct 2008. Available from: URL: http://pcmanet.org

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Generic carve-outs would increase costs by $US29b over next decade. Pharmacoecon. Outcomes News 564, 9 (2008). https://doi.org/10.2165/00151234-200805640-00023

    Download citation

    Keywords

    • Public Health
    • Health Outcome
    • Clinical Benefit
    • Health Economic
    • Prescription Drug